Skip to main content
. 2023 Jun 12;16:17562848231174277. doi: 10.1177/17562848231174277

Figure 2.

Figure 2.

Exposure to study treatment by treatment groups.

aParticipants who received blinded placebo + OL RBL (n = 48) are counted for both treatments.

bParticipants in PUNCH CD2, group C, were assigned to receive a placebo dose after their blinded dose of RBL. This did not impact the treatment group assignment for the integrated analysis.

OL, open-label; RBL, fecal microbiota, live-jslm.